Home›Breast Cancer›Clinical Implications from the TAILORx Trial

Clinical Implications from the TAILORx Trial

June 1, 2020

Jane L. Meisel, MD, discusses the clinical implications of the TAILORx trial and how it has affected practice.

Problem solver. Creator. Thinker. Web nerd. Food enthusiast. Pop culture junkie. Snowboarder, dreamer, hiphop head, hand letterer and growthhacker. Producing at the crossroads of modernism and programing to express ideas through design. I am 20 years old.